NCT03726125View on ClinicalTrials.gov

A Study of LY3374849 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

September 27, 2019

Study Completion Date

September 27, 2019

Conditions
Healthy
Interventions
DRUG

LY3374849 - SC

Administered SC

DRUG

Insulin Degludec - SC

Administered SC

DRUG

LY3374849 - IV

Administered IV

DRUG

Insulin Degludec - IV

Administered IV

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03726125 - A Study of LY3374849 in Healthy Participants | Biotech Hunter | Biotech Hunter